Outcome of Transphenoid Surgery for Corticotroph Pituitary Tumors
محل انتشار: مجله جراحی مغز و اعصاب ایران، دوره: 2، شماره: 1
سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 334
متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJN-2-1_003
تاریخ نمایه سازی: 10 تیر 1396
چکیده مقاله:
Background & Importance: The aim of this study was to demonstrate the result of transsphenoid microsurgery for Cushing disease in ourcenter and comparing the results in details with other articles, to achieve the best decision for patients management in future.Case Presentation: Between 1991 to 2015, 50 patients suffering from Cushing disease were operated. Before operation, endocrine testsand neuroimaging examinations were done for all patients and all of them were operated via transsphenoid approach. They were followedup in clinic with endocrine tests and imaging in regular intervals. During this study, 50 Cushing cases including 47 primary and threesecondary tumors were operated. Thirty four (68%) tumors were microadenoma and 16 (32%) macroadenoma. A patient died due to postoperativefulminant meningitis (mortality=2%). Mean of follow-up was five years. Overall, 40 (80%) patients had remission after operationand 9 (18%) patients achieved no remission, three of them had macroadenoma and six microadenoma. During follow-up period, three (6%)patients had recurrence which needed second operation. In secondary tumor and in macroadenoma with cavernous sinus involvement, theresult was not good (33% and 0% remission, respectively).Conclusion: Transsphenoid surgery is a safe and effective first choice method to manage Cushing disease compared to other treatmentmodalities. In recurrent or resistant cases, other modalities could help to manage patients.
کلیدواژه ها:
نویسندگان
Masoud Mehrazin
MD, Neurosurgeon, Professor of Neurosurgery, TUMS, Shariati Hospital, Tehran, Iran
Reza Mirfallah
MD, Neurosurgeon, Arad Hospital, Tehran, Iran
Hossein Bokaei
MD, ENT Surgeon, Arad Hospital, Tehran, Iran
Mousa Sadr-Hosseini
MD, ENT Surgeon, Associate Professor of ENT Surgery, TUMS, Imam Khomeini Hospital, Tehran, Iran